breast biopsy	is a	diagnostic procedure
core needle biopsy	is a	biopsy type
stereotactic biopsy	is a	biopsy type
vacuum-assisted biopsy	is a	biopsy type
fine-needle aspiration	is a	cytology procedure
open biopsy	is a	surgical procedure
incisional biopsy	is a	surgical procedure
excisional biopsy	is a	surgical procedure
mammography	is a	breast imaging test
ultrasound	is a	breast imaging test
MRI	is a	breast imaging modality
PET-CT	is a	diagnostic imaging test
mammography	detects	calcifications
mammography	detects	mass
ultrasound	detects	cyst
ultrasound	characterizes	lesion
MRI	detects	nonpalpable lesion
nonpalpable lesion	is detected by	MRI
biopsy	obtains	tissue sample
tissue sample	is analyzed by	pathology
pathology	provides	histology report
histology	identifies	tumor type
immunohistochemistry	determines	receptor status
ER status	determines	hormone receptor positivity
PR status	determines	hormone receptor positivity
HER2 status	determines	HER2 overexpression
receptor status	guides	therapy selection
ER status	guides	endocrine therapy
HER2 status	guides	targeted therapy
Ki-67	indicates	proliferation index
proliferation index	correlates with	tumor aggressiveness
ductal carcinoma in situ	is a	noninvasive cancer
invasive carcinoma	is a	malignant tumor
fibroadenoma	is a	benign lesion
breast cyst	is a	benign lesion
calcifications	are seen on	mammography
masses	are seen on	mammography
nonpalpable lesion	is seen on	ultrasound
calcifications	correlate with	DCIS
DCIS	is associated with	calcifications
sentinel lymph node biopsy	provides	nodal status
nodal status	determines	adjuvant therapy need
pathology report	informs	treatment plan
tumor	determines	cancer subtype
cancer subtype	informs	prognosis
hormone receptor positive tumor	predicts	endocrine therapy response
HER2-positive tumor	predicts	anti-HER2 therapy response
triple-negative tumor	lacks	hormone receptor expression
tissue diagnosis	confirms	cancer diagnosis
biopsy result	confirms	malignancy
biopsy result	rules out	benign lesion
benign lesion	requires	monitoring
imaging-guided biopsy	reduces	diagnostic delay
image-guided biopsy	minimizes	sampling error
staging workup	follows	tissue diagnosis
tumor size	influences	surgical planning
tumor size	affects	prognosis
calcifications	predict	DCIS risk
nonpalpable lesion	has	higher suspicion
mammography density	affects	image quality
dense breast	reduces	mammography sensitivity
ultrasound	guides	needle placement
stereotactic-guided biopsy	uses	mammograms
MRI-guided biopsy	uses	MRI
BI-RADS category	guides	biopsy decision
BI-RADS 4 lesion	prompts	biopsy
BI-RADS 5 lesion	prompts	biopsy
biopsy complication	includes	hematoma
biopsy complication	includes	infection
biopsy complication	includes	edema
patient age	correlates with	cancer risk
family history	increases	cancer risk
dense breast tissue	increases	biopsy need
imaging follow-up	occurs after	biopsy
benign biopsy result	reduces	biopsy necessity
malignant biopsy result	triggers	treatment planning
pathology subtyping	refines	prognosis
imaging surveillance	follows	treatment
tumor grade	influences	prognosis
treatment response	assessed by	pathology
neoadjuvant therapy	planned for	large tumors
post-biopsy imaging	confirms	lesion removal
resection specimen	provides	margins status
negative margins	indicate	complete excision
positive margins	require	re-excision
axillary ultrasound	evaluates	nodal status
sentinel node mapping	reduces	surgical extent
axillary dissection	replaces	sentinel node biopsy in some cases
adjuvant therapy	depends on	nodal status
adjuvant therapy	depends on	receptor status
biopsy	enables	accurate cancer staging
tissue biopsy	reduces	diagnostic uncertainty
imaging	complements	biopsy
ultrasound-guided biopsy	reduces	sampling error
staging imaging	complements	pathology
pathology	confirms	histologic subtype
hormone receptor status	guides	endocrine therapy
HER2 status	guides	HER2-targeted therapy
mammography	screens	population
diagnosis	communicates	prognosis
